Aortic Valve Stenosis: Symptoms, Treatment & When to Seek Care

Aortic valve stenosis is acquired or congenital stiffening and incomplete opening of the aortic valve that raises resistance at the left ventricular outflow tract. The ventricle responds with progressive concentric hypertrophy to preserve stroke volume, but eventually diastolic compliance worsens, stroke volume reserve falls, and the patient manifests exertional symptoms. Calcific degeneration of a trileaflet valve dominates older adults, whereas a congenitally bicuspid valve accelerates stenosis earlier in life; rheumatic fusion remains context-dependent globally. Obstruction is fixed in the sense that the mechanical orifice does not widen meaningfully with medical therapy, so once symptoms align with hemodynamically severe disease, the durable fix is valve replacement rather than prolonged adjustment of oral agents alone.

This page situates aortic valve disease alongside related lesions such as aortic regurgitation, but focuses on the high-gradient, low-orifice physiology unique to dominant stenosis.

Contemporary valve guidelines emphasise stage (A–D) by combining valve anatomy, haemodynamic severity, leaflet motion, and ventricular/remodelling consequences. Exact numeric cut-offs vary slightly between ACC/AHA and ESC writing groups and should be read against your local echo report template.

*Harmonise numeric criteria with the 2020 ACC/AHA and 2021 ESC/EACTS valvular heart disease documents—discordant “severe AVA / low gradient” cases mandate specialist echo (often dobutamine stress) rather than ward guesswork.

Early disease is often silent beyond a systolic murmur. Symptomatic severe disease classically triangulates angina-equivalent discomfort, exertional syncope, and progressive breathlessness—yet many patients drift into fatigue and reduced effort tolerance first.

• Exertional dyspnea or orthopnea pattern once LV filling pressures rise.
• Angina in the absence of epicardial disease because subendocardial perfusion is compromised by wall stress.
• Syncope related to arrhythmia, autonomic baroreceptor lag, or sudden drops in forward flow during activity.
• Dependent oedema and congestion when diastolic failure dominates.

Who skews atypical: frail older adults may attribute limits to deconditioning; people with small hyperdynamic ventricles can “feel fine” until AF abruptly unmasks obstruction; CKD-associated calcification can progress quietly—maintain a lower threshold for echo when chronic kidney disease coexists.

Mechanistic categories

• Calcific degeneration of a trileaflet valve—age, smoking history, hypertension, and atherosclerotic risk factors track with faster progression.
• Bicuspid aortic valve morphology with earlier superimposed calcification; often pairs with aortopathy requiring surveillance imaging of the ascending aorta.
• Rheumatic commissural fusion (geographic variability) producing mixed stenosis/regurgitation pictures.
• Rarer entities—severe annular calcification, radiation-associated fibrosis, unicuspid valves.

Modifiable vs non-modifiable (practical triage)

Valve leaflet thickening itself is not reversed by statins in established calcific AS, yet cardiovascular risk factor control still matters for perioperative safety and for concurrent coronary disease. Atorvastatin or other guideline-directed lipid therapy continues where indicated for global risk rather than expecting a gradient drop.

Clinical assessment

A harsh mid-to-late peaking systolic murmur at the right upper sternal border with radiation to the carotids, soft or absent A2 component when mobility is lost, and a paradoxically split S2 pattern in advanced disease are classic—but obesity, COPD, and tachycardia mute auscultation.

Laboratory investigations

• BNP or NT-proBNP trend when congestion is unclear—helpful for trajectory more than specificity.
• Creatinine/eGFR before contrast CT for TAVR planning or coronary angiography; heparin-based protocols during catheter procedures require baseline coagulation screens per unit policy.

Imaging

Transthoracic echocardiography quantifies velocities, valve area (continuity equation), dimensionless index, LV mass, diastolic function, and pulmonary pressures—often with Doppler-derived gradients. CT angiography of the aorta/iliofemoral arteries supports TAVR sizing; coronary angiography informs simultaneous revascularisation discussions before SAVR.

Diagnostic criteria in practice

Rely on the integrated multimodality report (imaging + symptoms + functional class). When echo indices disagree—especially low stroke volume states—refer for advanced imaging rather than anchoring on a single number.

• Murmur + exertional symptoms: same-day cardiology consult or direct outpatient echo per pathway; syncope or resting hypoxaemia merits ED evaluation.
• Echo shows severe AS: risk-stratify symptoms (NYHA), document rhythm, secure renal function, screen frailty markers if TAVR is plausible.
• Symptomatic severe AS: activate heart-team discussion for SAVR vs TAVR timeline; avoid elective non-cardiac surgery until addressed unless emergent and after sedation of risk.
• Asymptomatic severe AS with reduced exercise tolerance on routine activity: many centres pursue stress testing to objectify physiological limitation—coordinate before advising high-intensity training.
• Decompensated shock: ICU-level care, judicious inotrope/vasopressor selection, emergent balloon valvotomy only in select centres—never silent deterioration on general wards.

↔On a small screen, swipe or scroll sideways to see the full table.

First-line definitive therapy

• SAVR for durable mechanical or tissue prostheses when surgical risk is acceptable and coronary bypass or aortopathy repair may be bundled.
• TAVR for prohibitive or high surgical risk anatomies and suitable iliofemoral access—anticipate shorter recovery but vascular and conduction trade-offs.
• Balloon aortic valvotomy is palliative or bridge-only in selected paediatric or emergent scenarios—adults relapse quickly.

Medical therapy (supportive, not curative)

• Heart-failure diuretics cautiously—over-diuresis drops preload on a stiff LV.
• Rate control in AF: metoprolol or alternatives per cardiology; watch blood pressure and conduction.
• Anticoagulation strategy when AF coexists or after mechanical valve replacement—warfarin remains relevant for many mechanical valves though non–vitamin K antagonist rules differ by valve type and region.
• Avoid blind initiation of digoxin for rate control without expert oversight in obstruction.
• Antiplatelet plans (aspirin) follow centre-specific SAVR/TAVR protocols—do not assume triple therapy without bleeding review.

Special populations

Pregnancy increases preload and heart rate—severe AS should be managed in obstetric cardiology centres. Renal replacement therapy shifts calcium–phosphate balance and can accelerate valve calcification—integrate nephrology follow-up.

• Monitoring cadence: asymptomatic severe disease often earns 6–12 monthly clinical review with echo per pathway; shorten interval when LV dilates, pulmonary hypertension emerges, or gradients rise rapidly.
• Medication reconciliation: flag recent addition of nitrates, phosphodiesterase inhibitors, or aggressive antihypertensives in syncope-prone patients.
• Peri-procedure days: document baseline neurovascular checks before groin or radial access; maintain strict vital signs frequency per step-down orders; trend haemoglobin after sheath removal.
• Treatment failure signal: recurrent class III–IV symptoms within months of bioprosthesis suggests patient–prosthesis mismatch, paravalvular leak, or progressive coronary disease—trigger structural imaging review.
• Referral thresholds: any syncope, resting hypotension with narrow pulse pressure, refractory pulmonary oedema, or rising troponin with demand ischaemia should bypass routine clinic slots.
• MDT roles: heart-team coordinators organise imaging discs, anaesthetic review, and access-planning CT; nurses anchor functional status scoring honestly so consent discussions stay realistic.

• Sudden cardiac death from ischaemia or arrhythmia on fixed obstruction.
• Heart failure with reduced or preserved EF patterns once afterload–preload coupling fails.
• AF with rapid ventricular response and haemodynamic collapse.
• Infective endocarditis (especially prosthetic valves)—prolonged fever after intervention needs blood cultures before antibiotics unless unstable.
• GI angiodysplasia-associated bleeding (Heyde syndrome spectrum) in calcific AS—suspect when anaemia and AVWS pattern cluster.

Rheumatic fever primary prevention still matters where group A streptococcal disease is poorly treated. In calcific disease, evidence does not support slowing stenosis with statins alone, yet comprehensive ASCVD prevention simplifies coronary interventions if SAVR needs bypass. Ensure endocarditis counselling is accurate: prosthetic material, prior endocarditis, and specific congenital lesions alter prophylaxis eligibility per regional statements.

Asymptomatic moderate disease may remain stable for years. Symptomatic severe untreated AS carries stark short-term mortality; timely AVR restores expected survival toward age-matched controls when ventricular dysfunction is not end-stage. Bioprosthetic valves eventually degenerate—youthful patients need lifetime surveillance for reintervention planning.

Translation-heavy shifts run smoother when nurses rehearse three communication beats: what the murmur means in plain language, why nitroglycerin patches were held, and what symptoms should prompt a 999 call versus same-day clinic review. Family questions about “exercise” deserve cardiology-framed answers—patients in uncertain severity should not self-prescribe high-load resistance training before objective stress testing.

• Vital sign envelope: narrowing pulse pressure, new resting tachycardia, orthostasis after meds.
• Rhythm strip or telemetry: new LBBB, prolonged PR after TAVR, pauses.
• Respiratory pattern: orthopnea, new hypoxia, inability to lie flat.
• Access sites after femoral TAVR: expanding hematoma, delayed cap refill, pain out of proportion.
• Urine output tied to diuretic response—over-aggressive diuresis without ICU oversight drops preload dangerously.

• Witnessed cardiac arrest or unresponsive patient with no pulse—start Basic Life Support (BLS) and activate the resuscitation team per local protocol.
• Syncope with injury, recurrent ventricular pauses, or continued hypotension SBP <90 mmHg despite fluid bolus per protocol.
• SpO₂ <92% on baseline oxygen with pulmonary oedema refractory to initial therapy.
• Persistent crushing chest pain with haemodynamic instability—activate primary PCI pathway if ACS suspected while not neglecting AS as demand ischaemia.

Objective triggers for senior referral include rising lactate, falling mixed venous saturation if monitored, new troponin leak with ST depression, or bedside echo showing collapsing RV in setting of tamponade-equivalent physiology post-implant. Call the rapid response team when mentation, perfusion, or respiratory effort fail to stabilise within one structured treatment cycle; involve cardiothoracic surgery early if mechanical complications are suspected.

Pre-procedure

Confirm NPO status, reconcile anticoagulants, provide realistic fatigue expectations, and teach IV access hygiene if centralisation is planned.

Post-procedure

Maintain haemodynamic protocols after sheath removal, monitor for complete heart block, reassess pain and bleeding on a schedule, and screen delirium in older adults after long fluoroscopy cases.

Patient education & evaluation

Review anticoagulation bleeding precautions when vitamin K antagonists are prescribed, device safety with permanent pacemakers when implanted, and explicit return precautions for fever or neurologic change.

These NCLEX-style clinical judgment practice items focus on the nursing priorities for this condition — recognise cues, escalate red flags, take safe action and evaluate outcomes (NCSBN Clinical Judgment Measurement Model) — through Priority FIRST, SATA, deterioration trends, multi-patient triage, ordered response, matrix matching and a compact cloze on the topic of degenerative and bicuspid aortic stenosis, the angina / syncope / heart-failure triad and SAVR vs TAVI selection.